Mmj. Van Der Vorst et al., Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery, INTEN CAR M, 27(4), 2001, pp. 711-715
Objective: The commonly used continuous intravenous (IV) furosemide dosing
schedule after cardiac surgery in children is largely empirical and may not
be optimal. This may even be more marked in children after cardiac surgery
who are haemodynamically unstable, and in whom transient renal insufficien
cy may occur. A study was performed to obtain an impression regarding which
clinically applicable measures may be used to design a rational scheme for
continuous IV furosemide therapy in children after cardiac surgery.
Subjects and Methods: Twelve paediatric patients (5F/7 M, age 0-33 weeks) p
ost-cardiac surgery, who were to receive 3 days of continuous IV furosemide
treatment, were included in an open study. Blood and urine samples were ta
ken for furosemide, creatinine, and electrolyte levels, and fractionated ur
inary output was measured. Furosemide in blood and urine was measured using
high performance liquid chromatography (HPLC).
Results: The mean starting dose of continuous IV furosemide was 0.093 (+/-
0.016) mg/kg per hour. The mean dose was increased to 0.175 (+/- 0.045) mg/
kg per hour per hour on day 2, and changed to 0.150 (+/- 0.052) mg/kg per h
our on day 3. Infusion rates were increased from day 1 to day 2 in ten case
s, and decreased from day 2 to day 3 in three cases. Serum furosemide level
s never exceeded ototoxic levels. The urinary furosemide excretion rate war
s inversely related to serum creatinine levels.
Conclusions: This study extends the observation of the beneficial effects o
f continuous IV furosemide also to those children who are haemodynamically
unstable after cardiac surgery. However: as the effects of furosemide are d
ependent on renal function, it can be hypothesised that the dosing schedule
may be optimised. Contrary to the currently used dosage schedule in which
the dose of furosemide is gradually increased over time, it may be more rat
ional to start with a higher dose and adapt this dose (downward) guided by
the observed effect (urine output). Because the infusion rate was increased
to 0.2 mg/kg per hour in nine out of 12 patients on day 2 and was never in
creased further, this suggests that a starting rate of 0.2 mg/kg per hour m
ag; be optimal.